Thymidine kinase 1 combined with CEA, CYFRA21‐1 and NSE improved its diagnostic value for lung cancer

  title={Thymidine kinase 1 combined with CEA, CYFRA21‐1 and NSE improved its diagnostic value for lung cancer},
  author={Z Jiang and M. Wang and J. L. Xu},
  journal={Life Sciences},

Figures and Tables from this paper

Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer

FTO presents a high level in NSCLC cases, and joint detection of it with CEA or CYFRA21-1 delivered a higher specificity in diagnosing NSclC in contrast to detection of CEAor CYFra21- 1 alone, so the joint detection is worth popularizing in clinical scenarios.

Thymidine kinase 1 in serum for prognosis, an investigation on routine individual adapted treatment of non-small cell lung carcinoma.

STK1p correlates significantly to survival and is an independent multivariate prognostic factor in NSCLC patients, and is a useful tool to combine with imager for a rational approach to increase the efficacy in early detection of tumor in lung cancer screening and assessment of individual adjusted therapy in NSClC patients.

Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma

CYFRA21-1 and NSE may help to predict the response of ESCC to CRT, and play important roles in the diagnosis and recurrence monitoring of esophageal cancer.

Thymidine kinase 1 through the ages: a comprehensive review

Compared to other proliferation markers, TK1 levels during S phase more accurately determine the rate of DNA synthesis in actively dividing tumors, and is potentially more advantageous than current biomarkers.

CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancer

Serum circFOXP1 was an independent diagnostic molecule, and was significantly correlated with T stage and lymphatic metastasis in NSCLC, and highlighted the preferable diagnostic potential of serum circFO XP1 inNSCLC.

KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer

In vitro studies indicated that KLRK1 inhibited tumor cell proliferation and migration and may be a prognostic biomarker for lung adenocarcinoma cancer.

Neuron-Specific Enolase and Hemoglobin as Risk Factors of Intraocular Metastasis in Patients with Renal Cell Carcinoma

The result reveals that NSE and Hb represent promising significant risk factors of IOM for RCC patients, and Notably, Hb is more reliable than NSE in distinguishing case of Iom from NIOM in patients with RCC.

Prognostic significance of NDRG2 combined with EGFR patients with lung adenocarcinoma

NDRG2 and EGFR should be considered in patients with LUAD, after it was found that the patients in the NDRG 2-high/EGFR(+) group had the best outcomes, while the patients on the other hand had the worst outcomes.

Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis

The panel of CYFR21, CEA, NSE, and SCC seems to be a promising serum biomarker for the diagnosis of lung cancer, while the combination with carbohydrate antigen markers does not improve the diagnostic efficacy.

CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis

The combination of CA-125, CA-153 and CYFRA21-1 could help diagnose OM in male lung cancer patients and this finding might lead to more timely diagnosis and effective therapies.



Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer.

STK1 has prognostic value and is a reliable marker for monitoring the response to surgery of NSCLC patients, according to a study examining TK1 concentration in serum in 250 preoperative non-small cell lung cancer patients.

Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.

Combination detection of Hp, CEA, NSE and CYFRA21-1 could significantly improve the sensitivity and specificity in diagnosis of lung cancer, and could be useful for pathological typing.

Serum thymidine kinase 1 activity in breast cancer.

Elevated serum TK1 is an important risk factor indicating a high proliferation potential of tumors at the time of excision, and was found to be an independent prognostic factor for RFS.

CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis.

CYFRA21-1 level cannot be used as a urinary or serum biomarker for differentiating histological stages of local bladder cancer for histological grades I-III; there was also no difference in patients with stage IILocal bladder cancer and those with stage III local bladdercancer.

Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours.

STK1-values > 2 pM may indicate an early risk for development of malignancies years later, as compared to the STK1 negative group, due to higher mean ages of persons with proliferative breast and prostate tissues.

Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.

  • P. BroëtS. Romain F. Spyratos
  • Medicine, Biology
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2001
High TK values are an important risk factor in node-negative patients and seem to be associated with a beneficial effect of adjuvant FAC or FEC in patients who received adjUvant chemotherapy.

Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.

Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of early-stage NSCLC from benign lung disease.

The combination of positive SCC, positive CEA and positive Cyfra21-1 appear to be helpful in distinguishing early-stage NSCLC from benign lung disease which presented with suspicious pulmonary masses.

Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer

  • T. KorkmazS. Seber N. Turhal
  • Medicine, Biology
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
  • 2013
The magnitude of maximum fluorodeoxyglucose uptake in primary tumors and the serum TK1 level in patients with metastatic NSCLC were found to be independent prognostic predictors of overall survival.

Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

There are differences in the specific activities and the subunit compositions of STK1 in hematological malignancies compared with breast and prostate cancer, and this fact has several important implications for the use ofSTK1 as a tumor biomarker.